Spinout
Company formed to commercialize technology developed inside a university or larger organization, often with licensed intellectual property.
As defined in Biotech’s Chief Evangelist
Where it comes up · 1
- Biotech’s Chief Evangelist3 claims
Most important claims · 3 of 3Search all claims for “Spinout” →
- After Amicus stopped its first Pompe program, Head of Biology Hung Do proposed making a better enzyme paired with a small molecule, and Crowley says the company could not afford the restart, so Do left to found a company funded by his brother that later showed animal data, eight years after the program began.Biotech’s Chief Evangelist
- Most biotech companies come out of academic research, mostly in the United States, so university systems built over 100 to 200 years are the foundation of research and a strategic advantage that makes biotech a national imperative.Biotech’s Chief Evangelist
- Crowley argues that despite a tough three years, the next generation of university-spun technologies and a queue of higher-quality companies entering the IPO market at reasonable valuations makes the present a strong entry point for investors.Biotech’s Chief Evangelist